| Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations (NCT07640295) | Jacobio Pharmaceuticals Co., Ltd. | 2026-06-22 |
| The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC) (NCT07671924) | Trevi Therapeutics | 2026-06-22 |
| A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma (NCT07636772) | Akeso | 2026-06-22 |
| Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy (NCT07565415) | Nanfang Hospital, Southern Medical University | 2026-06-22 |
| A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus (NCT07509892) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-06-22 |
| A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) (NCT07602777) | GlaxoSmithKline | 2026-06-22 |
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes (NCT07668388) | Novo Nordisk A/S | 2026-06-22 |
| Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma (NCT07314216) | Hunan Cancer Hospital | 2026-06-22 |
| A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) (NCT07634471) | Merck Sharp & Dohme LLC | 2026-06-22 |
| Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma (NCT07657273) | Second Affiliated Hospital of Guangzhou Medical University | 2026-06-22 |
| Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia (NCT06364228) | University of Nebraska | 2026-06-20 |
| HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC (NCT07608224) | West China Hospital | 2026-06-20 |
| CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia (NCT07652905) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-20 |
| Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO) (NCT07665021) | Fondazione Telethon | 2026-06-20 |
| SYS6002 vs PADCEV in Patients With Advanced Urothelial Carcinoma (NCT07374549) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2026-06-20 |
| Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes (NCT06973109) | University of Pittsburgh | 2026-06-20 |
| A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial) (NCT07463820) | National Cancer Institute (NCI) | 2026-06-19 |
| A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity (NCT07724340) | Antag Therapeutics | 2026-06-19 |
| ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer (NCT07425054) | Jennifer Dorth | 2026-06-19 |
| A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT) (NCT07579949) | ScinnoHub Pharmaceutical Co., Ltd. | 2026-06-18 |
| Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms (NCT07693452) | University of California, Irvine | 2026-06-18 |
| The Effect of Osteoporotic Medications on Vertebral Bone Quality Score (NCT07587775) | State University of New York at Buffalo | 2026-06-18 |
| Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine (NCT07661940) | University of Erlangen-Nürnberg Medical School | 2026-06-18 |
| CW-301 FIH Study of CAN016 (NCT07664150) | Canwell Biotech Limited | 2026-06-18 |
| Long-Term Outcomes Following HBOT (NCT07732374) | Summit Hyperbarics and Wellness | 2026-06-18 |
| A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB) (NCT07640984) | JCR Pharmaceuticals Co., Ltd. | 2026-06-18 |
| Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor (NCT07673107) | AbbVie | 2026-06-18 |
| A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis (NCT07551427) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-06-18 |
| Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL) (NCT07668960) | Shanghai Mianyi Biopharmaceutical Co., Ltd. | 2026-06-17 |
| Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus (NCT06593392) | Vifor Fresenius Medical Care Renal Pharma | 2026-06-17 |
| Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients (NCT06513949) | Implicit Bioscience | 2026-06-17 |
| Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation (NCT07012031) | National Cancer Institute (NCI) | 2026-06-17 |
| A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) (NCT07501559) | Jecho Biopharmaceuticals Co., Ltd. | 2026-06-17 |
| Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT) (NCT07447076) | Sabine Mueller, MD, PhD | 2026-06-17 |
| Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07638436) | Sun Yat-sen University | 2026-06-17 |
| Ongoing Lung Decline With Age Intensified Response (NCT07676435) | Cedars-Sinai Medical Center | 2026-06-17 |
| A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia (NCT07477704) | Regeneron Pharmaceuticals | 2026-06-17 |
| A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy (NCT07564401) | Novartis Pharmaceuticals | 2026-06-16 |
| CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk (NCT07615348) | Jinling Hospital, China | 2026-06-16 |
| Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission (NCT07507318) | Rong Tao | 2026-06-16 |
| IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors (NCT07508761) | Nanjing Immunophage Biotech Co., Ltd | 2026-06-16 |
| Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II Study (NCT07636824) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-06-16 |
| Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP (NCT07656909) | Yi Ji | 2026-06-16 |
| Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma (NCT07677813) | Ou Bai, MD/PHD | 2026-06-16 |
| Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma (NCT07632339) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-06-16 |
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer (NCT07644559) | Verastem, Inc. | 2026-06-16 |
| Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma (NCT07392957) | Washington University School of Medicine | 2026-06-16 |
| A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA) (NCT07606274) | Nuevocor Pte. Ltd. | 2026-06-16 |
| CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (NCT07328503) | National Cancer Institute (NCI) | 2026-06-16 |
| A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance (NCT07622550) | Jiangsu Cancer Institute & Hospital | 2026-06-15 |
| A1Cantus vs. Placebo (NCT07585630) | University of California, Riverside | 2026-06-15 |
| GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial (NCT07613437) | Chinese University of Hong Kong | 2026-06-15 |
| A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 (NCT07645287) | Gilead Sciences | 2026-06-15 |
| Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients (NCT06916585) | Shenzhen Third People's Hospital | 2026-06-15 |
| KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly Diagnosed POEMS Syndrome (NCT07652879) | Shanghai Changzheng Hospital | 2026-06-15 |
| Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation (NCT06634056) | University Health Network, Toronto | 2026-06-15 |
| Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease (NCT07641140) | Lingyi Biotech Co., Ltd. | 2026-06-15 |
| Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies (NCT07636486) | Nanfang Hospital, Southern Medical University | 2026-06-15 |
| Furosemide vs Placebo in Severe Preeclampsia Postpartum (NCT07648251) | Universidad Nacional Autonoma de Honduras | 2026-06-15 |
| A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. (NCT07365319) | Eikon Therapeutics | 2026-06-15 |
| Perioperative Fruquintinib Combined With Sintilimab and SOX for Locally Advanced Gastric or GEJ Adenocarcinoma (NCT07658872) | Sichuan University | 2026-06-15 |
| Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor (NCT07631884) | Haihua Yuan | 2026-06-15 |
| Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial (NCT07436793) | New Mexico Cancer Research Alliance | 2026-06-15 |
| Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis (NCT07639177) | Peking Union Medical College Hospital | 2026-06-15 |
| Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors (NCT07688356) | Samsung Medical Center | 2026-06-15 |
| Melissa Officinalis Aromatherapy for Dental Anxiety in Children (NCT07592130) | Universidad Autonoma de San Luis Potosí | 2026-06-15 |
| A Study to Understand How a New, Unlicensed Drug (AIC468) Works, Compared With a Placebo, Against BK Virus in Patients Who Have Had a Kidney Transplant. (NCT07503561) | AiCuris Anti-infective Cures AG | 2026-06-15 |
| QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer (NCT07617818) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-06-15 |
| PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy (NCT07644208) | Shanghai Zhongshan Hospital | 2026-06-15 |
| Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL (NCT07638787) | Ruijin Hospital | 2026-06-15 |
| An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy (NCT07631871) | Haihua Yuan | 2026-06-15 |
| Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine (NCT07683949) | Seoul National University Bundang Hospital | 2026-06-15 |
| A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR). (NCT06997159) | Drugs for Neglected Diseases | 2026-06-15 |
| Ipilimumab (N01) Plus Sintilimab and Modified XELOX as Conversion Therapy in Unresectable Locally Advanced Gastric Cancer (NCT07638631) | Chen Lizhu | 2026-06-15 |
| N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors (NCT07639450) | Hefei Xinzhu Biological Technology Co., Ltd. | 2026-06-15 |
| Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and Chemotherapy (NCT07573696) | Wen-zhao ZHONG | 2026-06-15 |
| Colchicine for Autoimmune and Subacute Thyroiditis (NCT07571681) | Mansoura University | 2026-06-15 |
| Phase II, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids as an Adjunct to Morphine in Acute Postoperative Pain (NCT07657468) | National University of La Rioja | 2026-06-15 |
| A Study of DAT-2645 in Patients With BRCA1/2 Mutations or HRD-Positive Ovarian Cancer (NCT07652073) | Danatlas Pharmaceuticals Co., Ltd | 2026-06-15 |
| Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) (NCT07625332) | Northwell Health | 2026-06-15 |
| Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV (NCT07726433) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-15 |
| Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans (NCT07646080) | Yanjie Zhang, MD | 2026-06-15 |
| A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease (NCT07647133) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2026-06-15 |
| A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough (NCT07690059) | Sensory Cloud, Inc. | 2026-06-15 |
| Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study (NCT07637877) | Beijing 302 Hospital | 2026-06-15 |
| Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer (NCT07638501) | Eastern Hepatobiliary Surgery Hospital | 2026-06-15 |
| Etrasimod as Prevention of Pouchitis (NCT07486921) | Maia Kayal | 2026-06-12 |
| Telerehabilitation and Biomarkers of Recovery After Stroke in Brazil (NCT07646522) | University of Sao Paulo | 2026-06-12 |
| Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients (NCT07507760) | PETHEMA Foundation | 2026-06-12 |
| A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism (NCT07646535) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2026-06-12 |
| Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis (NCT07475286) | Mohammad Haroon Asif Choudry | 2026-06-12 |
| Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial (NCT07643103) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-12 |
| A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (NCT07553299) | Verdiva Bio Dev Limited | 2026-06-12 |
| A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL (NCT07607925) | GlaxoSmithKline | 2026-06-12 |
| Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI (NCT07658105) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-12 |
| Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia (NCT07620938) | Hangzhou PhecdaMed Co., Ltd. | 2026-06-12 |
| MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma (NCT07517705) | University of Nebraska | 2026-06-12 |
| Cannabidiol for Pain Relief of Patients With End-stage mCRPC (NCT07549256) | Regionshospital Nordjylland | 2026-06-12 |
| Study of D-2570 in Subjects With Non-Segmental Vitiligo (NCT07625891) | InventisBio Co., Ltd | 2026-06-11 |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. (NCT07652658) | AstraZeneca | 2026-06-11 |